| 1 |
35106453 | Attenuation of SARS-CoV-2 infection by losartan in human kidney organoids. | 2022 Feb 18 |
1 |
| 2 |
35359831 | Oral Lisinopril Raises Tissue Levels of ACE2, the SARS-CoV-2 Receptor, in Healthy Male and Female Mice. | 2022 |
2 |
| 3 |
33294307 | Are losartan and imatinib effective against SARS-CoV2 pathogenesis? A pathophysiologic-based in silico study. | 2021 |
1 |
| 4 |
34529122 | Soluble angiotensin-converting enzyme levels in heart failure or acute coronary syndrome: revisiting its modulation and prognosis value. | 2021 Dec |
2 |
| 5 |
34631362 | Molecular modeling of the interaction of ligands with ACE2-SARS-CoV-2 spike protein complex. | 2021 |
1 |
| 6 |
34646263 | Preliminary Evidence for IL-10-Induced ACE2 mRNA Expression in Lung-Derived and Endothelial Cells: Implications for SARS-Cov-2 ARDS Pathogenesis. | 2021 |
1 |
| 7 |
34937861 | Correlation of ACE2 with RAS components after Losartan treatment in light of COVID-19. | 2021 Dec 22 |
1 |
| 8 |
18403595 | Angiotensin II up-regulates angiotensin I-converting enzyme (ACE), but down-regulates ACE2 via the AT1-ERK/p38 MAP kinase pathway. | 2008 May |
1 |